Can an FDA-approved drug help halt vision loss in MS?
News
Deadline approaching to apply for OMRF summer program
Final date to apply is Feb. 1
The life-changing impact of clinical trials
“OMRF has saved my life,” says MS patient Tonja Martin.
OMRF scientist receives $300,000 from Lupus Research Alliance
The Lupus Research Alliance is the world’s leading private funder of lupus research.
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.